Full Press Release Details
information: Michael R. Cox
Announces Compliance with NASDAQ Capital Markets Requirements
LAFAYETTE, IN, November 19, 2009 - Bioanalytical Systems, Inc.
(NASDAQ: BASI) announced today that its application to transfer from the NASDAQ
Stock Market to the NASDAQ Capital Market has been accepted. The
transfer will occur on November 20, 2009.
The Company had previously been
informed by the NASDAQ Stock Market that it did not meet minimum market value of
publicly held shares and minimum bid price per share requirements. As
a result of an increase in the market value of its stock, and lower minimum
market value of publicly held shares for the Capital Market, the Company is now
in compliance with the Capital Market requirements.
pharmaceutical development company providing contract research services and
monitoring instruments to the world's leading drug development companies and
medical research organizations. The company focuses on developing
innovative services and products that increase efficiency and reduce the cost of
taking a new drug to market. Visit www.BASInc.com for
more information about BASi.
release may contain forward-looking statements that are subject to risks and
uncertainties including, but not limited to, those market and operating risks
detailed in the company's filings with the Securities and Exchange